CUVLNasdaqAmerican Depositary ReceiptsFiscal year ends June 30Also trades as CLVLF
Clinuvel Pharmaceuticals Ltd
$5.24+0.00 (+0.10%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Clinuvel Pharmaceuticals
American Depositary Receipts, SIC 8880
Clinuvel Pharmaceuticals Ltd is listed on Nasdaq under the ticker CUVL, in the SEC industry American Depositary Receipts. It is incorporated in C3 and its fiscal year ends on June 30.
Company profile
Company
- Legal name
- Clinuvel Pharmaceuticals Ltd
- Headquarters
- Melbourne, Victoria, Australia
- Address
- Level 10, 52 Collins Street
- Phone
- (650) 656-0284
- Industry
- American Depositary Receipts
- Incorporated in
- C3
- Fiscal year ends
- June 30
Stock & identifiers
- Ticker
- CUVL
- Other tickers
- CLVLF
- Exchange
- Nasdaq
- IPO date
- Jan 30, 2008
- SEC CIK
- 1290877
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Clinuvel Pharmaceuticals's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 20, 2006 | Name change | Name changed from EpiTan LTD to Clinuvel Pharmaceuticals Ltd |